Gratus Capital LLC Horizon Therapeutics Public LTD CO Transaction History

Gratus Capital LLC

  • $2.1 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023
BUY
$98.98 - $115.74 $31,673 - $37,036
320 Added 5.11%
6,579 $761,000
Q2 2023

Aug 02, 2023
SELL
$96.34 - $112.38 $5,684 - $6,630
-59 Reduced 0.93%
6,259 $643,000
Q1 2023

Apr 19, 2023
BUY
$107.32 - $113.5 $678,047 - $717,093
6,318 New
6,318 $689,000

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Gratus Capital LLC Portfolio

Follow Gratus Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email